Arthroscopically-Deliverable Regenerative Osteochondral Implant Technology. This project, in partnership with JRI Orthopaedics Ltd and Spheritech, will for the first time ever develop a biomaterial that can be implanted using ‘keyhole’ (arthroscopy) or open surgery, specifically to regrow the joint surface in the early-stages OA. The biomaterial, Proliferate® has been used successfully to regenerate many tissues already including, skin, liver and nerves. This project will give all the evidence needed to take it into the clinic, get a CE mark and start treating patients with OA early before total joint replacement is their only option.
The funding of £545,357 comes from the Technology Strategy Board through the Biomedical Catalyst scheme, and the project runs from January 2017 to December 2018. Dr Frances Henson is Principal Investigator.